Science
COVID-19 data scandal prompts tweaks to elite journal’s review process – Science Magazine
After publishing study based on unverified patient data from Surgisphere, a little-known company, The Lancet promises tighter standards
By Kelly ServickSep. 18, 2020 , 2:40 PM
Sciences COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
Three months after retracting a high-profile COVID-19 paper, editors at The Lancet hope to assure the research community that theyve learned their lesson. The journal yanked a study on risks of hydroxychloroquinean antimalarial drug whose proposed use as a COVID-19 treatment has stirred scientific and political controversyin June when its authors couldnt pr…
Continue Reading
